Uncategorized

ESHRE 2015 – Invitation, part 2 !

INVICTA Genetic Laboratory is pleased to invite you to visit our stand during the 31st Congress of the European Society of Human Reproduction and Embryology (ESHRE) […]

Read more

Helping to avoid miscarriages – FertiGenes Test™ – Miscarriages

Women who had experienced at least two miscarriages can perform a test to detect mutations in genes predisposing them to the development of thromboembolism (thrombosis). Blood […]

Read more

How to choose a test ?

Appropriate plan for diagnostic testing can be prepared with help from a clinical geneticist. After an interview and examination of patient’s situation, she will be able […]

Read more

Implantation rate with PGS-NGS 360°™ up to 61,5% – as published in Fertility & Sterility

It is well established that human oocytes are extremely often aneuploid. It is the most common chromosome abnormality in humans and the leading genetic cause of […]

Read more

Success rates with PGS-NGS 360°™ up to 84,4% – as published in Fertility & Sterility

Even in young women more than 50% of cleavage-stage embryos are chromosomally abnormal and it increases up to almost 100% with woman’s age. Aneuploidies are very […]

Read more

Genetic Testing – who should do it ?

Thanks to genetic testing, doctors can now read information contained in the DNA of every human being. DNA determines not only about how we look, but […]

Read more

INVICTA PGD ONE – One procedure, multiple benefits.

Do the couples carrying gene mutations which condition autosomally inherited diseases have to be exposed to a 25% risk of giving birth to an ill child? […]

Read more

Genetic Laboratory No 1 in Poland !

The INVICTA Genetic Laboratory has been awarded the first place among private health care centers in the ranking prepared by one of the most popular newspapers […]

Read more